Neoleukin Therapeutics Inc
Change company Symbol lookup
Select an option...
NLTX Neoleukin Therapeutics Inc
CTO CTO Realty Growth Inc
WHR Whirlpool Corp
OTIS Otis Worldwide Corp
GME GameStop Corp
ECF Ellsworth Growth and Income Fund Ltd
SILK Silk Road Medical Inc
HLVX Hillevax Inc
AIZ Assurant Inc
NOTV Inotiv Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Neoleukin Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. The Company's lead product candidate, NL-201, is an interleukin-2 (IL-2)/ interleukin-15 (IL-15) immunotherapy designed to eliminate binding to the alpha subunit of the IL-2 receptor (also known as CD25) while enhancing binding to the beta and gamma subunits. NL-201 is designed to mimic the therapeutic activity of the cytokines IL-2 and IL-15 for the treatment of various types of cancer, including renal cell carcinoma (RCC), melanoma and hematological malignancies. Its Neoleukin platform uses a set of advanced computational algorithms and methods to design functional de novo proteins. NL-201 holds promise in combination with cell therapy to expand and maintain populations of transplanted CAR-T and natural killer (NK) cells.

Closing Price
$0.59
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
40,499

10-day average volume:
60,091
40,499

Principal Financial Group Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

5:16 pm ET October 31, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Principal Financial Group Inc. (PFG) inched 0.14% higher to $88.13 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.75% to 3,871.98 and Dow Jones Industrial Average falling 0.39% to 32,732.95. This was the stock's seventh consecutive day of gains. Principal Financial Group Inc. closed $0.18 below its 52-week high ($88.31), which the company achieved on October 28th.

The stock underperformed when compared to some of its competitors Monday, as AFLAC Inc. (AFL) rose 0.49% to $65.11, Assurant Inc. (AIZ) rose 0.87% to $135.86, and Aegon N.V. ADR (AGN.AE) rose 0.22% to $4.61. Trading volume (2.5 M) eclipsed its 50-day average volume of 1.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 31, 2022.

	

(END) Dow Jones Newswires

October 31, 2022 17:16 ET (21:16 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.